{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:17:57Z","timestamp":1760955477446},"reference-count":35,"publisher":"SLACK, Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.3928\/0090-4481-20030901-07","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T17:49:53Z","timestamp":1401212993000},"page":"585-591","source":"Crossref","is-referenced-by-count":7,"title":["New Methods Advance Treatment for Respiratory Distress Syndrome"],"prefix":"10.3928","volume":"32","author":[{"given":"Alfred N","family":"Kraus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1 . Krauss AN. Recent advances in hyaline membrane disease. Pediatr Ann. 1983;12(1):2430.","DOI":"10.3928\/0090-4481-19830101-02"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. Avery ME Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AmJDis Child. 1959;97:517-523.","DOI":"10.1001\/archpedi.1959.02070010519001"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"3. Clements JA. Lung surfactant: A personal perspective. Annu Rev Physiol. 1997;59:1-21.","DOI":"10.1146\/annurev.physiol.59.1.1"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. Jobe AH Dcegami M. Biology of surfactant. Clin Perinatol. 2001;28(3):655-669.","DOI":"10.1016\/S0095-5108(05)70111-1"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Whitsett JA Weaver TE. Hydrophobic surfactant proteins in lung function and disease. New Eng J Med. 2002;347(26):2141-2148.","DOI":"10.1056\/NEJMra022387"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Liggins GC. Premature delivery of fetal lambs infused with glucocorticoids. J Endocrinol 1969;45:515.","DOI":"10.1677\/joe.0.0450515"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Liggins GC Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):5 15-525.","DOI":"10.1542\/peds.50.4.515"},{"key":"e_1_3_1_9_1","unstructured":"8. American Academy of Pediatrics. Guidelines for Perinatal Care. 5th ed. Elk Grove 111: AAP; 2002:170-171."},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. Suresh GK Soll RF. Current surfactant use in premature infants. Clin Perinatol. 2001 ;28(3):67 1-694.","DOI":"10.1016\/S0095-5108(05)70112-3"},{"key":"e_1_3_1_11_1","unstructured":"10. Drugdex Drug Evaluations. Beractant. Micromedex Healthcare Series 2003; vol. 115."},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Findlay RD Taeusch HW Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics. 1996;97(l):48-52.","DOI":"10.1542\/peds.97.1.48"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Herting E Gefeller O Land M et al.. Collaborative European Multicenter Study Group. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics. 2000;106(5):957-964.","DOI":"10.1542\/peds.106.5.957"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Wiswell TE. Expanded uses of surfactant therapy. Clin. Perinatol. 200l;28(3):695-711.","DOI":"10.1016\/S0095-5108(05)70113-5"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Northway WH Rosan RC Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: Bronchopulmonary dysplasia. New Eng J Med. 1967;276(7):357-368.","DOI":"10.1056\/NEJM196702162760701"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Philip AG. Oxygen plus pressure plus time: The etiology of bronchopulmonary dysplasia. Pediatrics. 1975;55(l):44-50.","DOI":"10.1542\/peds.55.1.44"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"16. Avery ME Tooley WH Keller JB et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987;79(l):26-30.","DOI":"10.1542\/peds.79.1.26"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Greenough A. Update of patient-triggered ventilation. Clin Perinatol. 200I;28(3):533546.","DOI":"10.1016\/S0095-5108(05)70105-6"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"18. Ware LB Matthay MA. The acute respiratory distress syndrome. New Eng J Med. 2000 342(1 8): 1334- 1349.","DOI":"10.1056\/NEJM200005043421806"},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"19. Carlo WA Stark AR Wright LL et al. Minimal ventilation to prevent bronchopulmonary dysplasia in extremely low-birth-weight infants. J Pediatrics. 20O2;141(3):370-375.","DOI":"10.1067\/mpd.2002.127507"},{"key":"e_1_3_1_21_1","unstructured":"20. Coghill CH Carlo WA Martin RJ. High-frequency jet ventilation. In: Boynton BR Carlo WA Jobe AH eds. New Therapies for Neonatal Respiratory Failure: a physiological approach. New York NY: Cambridge University Press; 1994:218-259."},{"key":"e_1_3_1_22_1","doi-asserted-by":"crossref","unstructured":"21 . Johnson AH Peacock JL Greenough A et al. High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. New Eng J Med 2002;347(9):633-642.","DOI":"10.1056\/NEJMoa020432"},{"key":"e_1_3_1_23_1","unstructured":"22. Courtney SE Durand DJ Asselin JM et al."},{"key":"e_1_3_1_24_1","doi-asserted-by":"crossref","unstructured":"High-frequency oscillatory ventilation versus conventional mechanical ventilation for verylow-birth-weight infants. New Eng J Med 2002;347(9):643-652.","DOI":"10.1056\/NEJMoa012750"},{"key":"e_1_3_1_25_1","doi-asserted-by":"crossref","unstructured":"23. Gersony WM. Persistence of the fetal circulation: a commentary. J Pediatr. 1973;82(6):1 103-1 106.","DOI":"10.1016\/S0022-3476(73)80472-X"},{"key":"e_1_3_1_26_1","doi-asserted-by":"crossref","unstructured":"24. Bartlett RH Roloff DW Cornell RG et al. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics. 1985;76(4):479-487.","DOI":"10.1542\/peds.76.4.479"},{"key":"e_1_3_1_27_1","doi-asserted-by":"crossref","unstructured":"25. Rudolph AM Yuan S. Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest. 1966;45(3):399-411.","DOI":"10.1172\/JCI105355"},{"key":"e_1_3_1_28_1","doi-asserted-by":"crossref","unstructured":"26. Peckham GJ Fox WW. Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertension. J Pediatrics. 1978;93(6): 1005-1010.","DOI":"10.1016\/S0022-3476(78)81239-6"},{"key":"e_1_3_1_29_1","doi-asserted-by":"crossref","unstructured":"27. Shalak L Perlman JM. Hemorrhagicischemic cerebral injury in the preterm infant: current concepts. Clin Perinatol. 2002;29(4):745-763.","DOI":"10.1016\/S0095-5108(02)00048-9"},{"key":"e_1_3_1_30_1","doi-asserted-by":"crossref","unstructured":"28. Fujimoto S Togari H Yamaguchi N et al. Hypocarbia and cystic periventricular leukomalacia in premature infants. Arch Dis Child. 1994;71(2):F107-110.","DOI":"10.1136\/fn.71.2.F107"},{"key":"e_1_3_1_31_1","unstructured":"29. Bifano EM Pfannenstiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics. 1988;81(4):657-661."},{"key":"e_1_3_1_32_1","unstructured":"30. Roberts JD Abman SH. Physiology of nitric oxide in the perinatal lung. In: Boynton BR Carlo WA Jobe AH eds. New Therapies for Neonatal Respiratory Failure: a physiological approach. New York NY: Cambridge University Press; 1994:339-348."},{"key":"e_1_3_1_33_1","doi-asserted-by":"crossref","unstructured":"31. Walsh MC Stork EK. Persistent pulmonary hypertension of the newborn. Clin. Perinatol. 2001;28(3):609-627.","DOI":"10.1016\/S0095-5108(05)70109-3"},{"key":"e_1_3_1_34_1","doi-asserted-by":"crossref","unstructured":"32. Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of NINOS. J Pediatrics. 2000; 136(5):61 1-617.","DOI":"10.1067\/mpd.2000.104826"},{"key":"e_1_3_1_35_1","unstructured":"33. Finer NN Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term (Cochrane Review). In: The Cochrane Library Issue 1 2003. Oxford: Update Software."},{"key":"e_1_3_1_36_1","doi-asserted-by":"crossref","unstructured":"34. American Academy of Pediatrics Committee on Fetus and Newborn. Use of inhaled nitric oxide. Pediatrics. 2000; 106(2 Pt l):344-345.","DOI":"10.1542\/peds.106.2.344"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/0090-4481-20030901-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:41:08Z","timestamp":1683114068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0090-4481-20030901-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.3928\/0090-4481-20030901-07"],"URL":"https:\/\/doi.org\/10.3928\/0090-4481-20030901-07","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}